Publications
- Tezepelumab - a novelty in the treatment of severe asthma2023 | Faculty of Medicine in Pilsen
- Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study2022 | Faculty of Medicine in Pilsen
- Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech anti-IgE registry2020 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic2019 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Application "Severe asthma" - a new tool for doctors and patients2019 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Anti-IgE monoclonal antibody therapy for severe bronchial asthma and other allergic disease2019 | Second Faculty of Medicine
- Mepolizumab in treating severe asthma2016 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- NUT midline pulmonary carcinoma - molecular profiling of three cases and a literature review of the per-spectives for precision oncology2023 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Practical pneumology2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps2020 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Loading network view...